Spero Therapeutics Inc (SPRO) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.00x
Spero Therapeutics Inc (SPRO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $17.42 Million. Explore Spero Therapeutics Inc (SPRO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$17.42 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Spero Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Spero Therapeutics Inc. For live market cap and broader valuation context, see Spero Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow